Latest Articles

Publication Date
All News Scientific
Safety of 48 months of elagolix with add-back therapy for endometriosis-associated pain.

Elagolix (ELA) 200 mg twice daily is an oral treatment approved for moderate-to-severe endometriosis-associated pain. However, the clinical use of ELA is limited by potential hypoestrogenic effects, including the loss …

Published: Nov. 7, 2025, midnight
Read Full Article
bone mineral density elagolix endometriosis estradiol pain pelvic pain safety
Endometrial Cancer Market Poised for Expansion Throughout Forecast Period (2025-2034) Amid Increasing Adoption of Immunotherapies | DelveInsight - The Malaysian Reserve

Endometrial Cancer Market Poised for Expansion Throughout Forecast Period (2025-2034) Amid Increasing Adoption of Immunotherapies | DelveInsight The Malaysian Reserve

Published: Nov. 6, 2025, 11:33 p.m.
Read Full Article
Endometrial Cancer Market Poised for Expansion Throughout Forecast Period (2025-2034) Amid Increasing Adoption of Immunotherapies | DelveInsight - PR Newswire UK

Endometrial Cancer Market Poised for Expansion Throughout Forecast Period (2025-2034) Amid Increasing Adoption of Immunotherapies | DelveInsight PR Newswire UK

Published: Nov. 6, 2025, 10:31 p.m.
Read Full Article
Endometrial Cancer Market Poised for Expansion Throughout Forecast Period (2025-2034) Amid Increasing Adoption of Immunotherapies | DelveInsight - Yahoo Finance

Endometrial Cancer Market Poised for Expansion Throughout Forecast Period (2025-2034) Amid Increasing Adoption of Immunotherapies | DelveInsight Yahoo Finance

Published: Nov. 6, 2025, 10:31 p.m.
Read Full Article
The 13th Asian Endometriosis Congress held in Colombo - Daily Mirror - Sri Lanka

The 13th Asian Endometriosis Congress held in Colombo Daily Mirror - Sri Lanka

Published: Nov. 6, 2025, 10:19 p.m.
Read Full Article
HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health - The Malaysian Reserve

HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health The Malaysian Reserve

Published: Nov. 6, 2025, 8:25 p.m.
Read Full Article
Natalie had problems with painful menstruation for years: A hidden disease almost cost her her life! - lnginnorthernbc.ca

Natalie had problems with painful menstruation for years: A hidden disease almost cost her her life! lnginnorthernbc.ca

Published: Nov. 6, 2025, 8:09 p.m.
Read Full Article
Channel Medsystems Surpasses 5,000 Cerene® Cryotherapy - GlobeNewswire

Channel Medsystems Surpasses 5,000 Cerene® Cryotherapy GlobeNewswire

Published: Nov. 6, 2025, 4 p.m.
Read Full Article
Cedars-Sinai Experts Highlight Advances in Minimally Invasive Gynecologic Surgery - Cedars-Sinai

Cedars-Sinai Experts Highlight Advances in Minimally Invasive Gynecologic Surgery Cedars-Sinai

Published: Nov. 6, 2025, 4 p.m.
Read Full Article
Association Between Previous Surgical Treatment and Outcomes of Repeat Endometriosis Surgery - medtalks.in

Association Between Previous Surgical Treatment and Outcomes of Repeat Endometriosis Surgery medtalks.in

Published: Nov. 6, 2025, 11:13 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!